secwatch.observer — SEC 8-K summary
======================================

Issuer:     Liquidia Corp (LQDA)
CIK:        0001819576
Form:       8-K
Filed at:   2024-01-23T23:59:59+00:00
Accession:  0001104659-24-005743
Event type: litigation
Sentiment:  positive
Materiality: 0.55
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Liquidia: United Therapeutics dismisses '793 Patent claims in PH-ILD litigation; '327 Patent remains
--------------------------------------------------------------------------------

- On Jan 22, 2024, United Therapeutics stipulated to dismiss all claims related to the '793 Patent in the New Hatch-Waxman Litigation.
- Only claims related to the '327 Patent remain; Liquidia asserts the '327 Patent does not entitle a 30-month regulatory stay.
- The dismissal does not affect the injunction issued in the Original Hatch-Waxman Litigation (filed June 2020).
- Liquidia's motion to set aside the original injunction is fully briefed; awaiting the District Court's decision.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819576/000110465924005743/0001104659-24-005743-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819576/000110465924005743/tm243890d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-005743

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer